Dietary Protein

2

Review clinical trials related to Dietary Protein. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)

The goal of this intervention study is to evaluate the difference in nutrition status markers (weight and muscle mass) when giving dietary protein by continuous or bolus delivery in critically ill children ages 1-11y. The main questions it aims to answer are: Primary: Bolus protein delivery will lessen the decline in mid-upper arm circumference (MUAC) z-score by 0.5 standard deviation in critically ill children aged 1-11y after 1wk. Ultrasound will correlate to MUAC. Secondary: Bolus protein delivery will provide more (grams per day) than when provided continuously, therefore it is more likely to meet the minimum estimated needs. Participants will have daily nutrition intake data collected, and undergo body composition measures (weight, MUAC and ultrasound of the upper thigh muscle) at day of enrollment, and MUAC/Ultrasound on follow up days 3, 5, 7 and 14 after the intervention started.

Participants needed: 96
Trial details
Age: 1-11Biological sex: AllType: InterventionalSponsor: University of British ColumbiaUpdated: Feb 12, 2026Locations: 1
Eligibility criteria

Children admitted to PICU over 1 year of age and younger than 11 years of life [+2]

Neuromuscular condition such as muscular dystrophy [+5]

Status: Not yet recruiting

Dietary Protein Sources and Glycemic Variability

This goal of trial is to evaluate the effects of plant-based vs. animal-based diets on glycemic variability in overweight or obese adults through a 3-week dietary intervention. The main question it aims to answer is: Will a plant-based diet be able to reduce glycemic variability in overweight or obese adults compared with an animal-based diet? Participants will strictly follow a designated plant-based or animal-based dietary regimen throughout the duration of the 3-week study. They will wear a Continuous Glucose Monitor (CGM) throughout the study, engage in weekly clinical assessments, and record their daily dietary intake.

Participants needed: 96
Trial details
Age: 20-65Biological sex: AllType: InterventionalSponsor: Guangdong Provincial People's HospitalUpdated: Jul 31, 2024
Eligibility criteria

Men or women aged 20-65 years. [+6]

With diagnosed diabetes. [+9]